INNT
TOTAL INVALIDATION PROCESSED BY THE IB
16/07/2026
Voltar para busca
Dado oficial do USPTO
BIOCELLIC+
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
45
Atualização mais recente
16/07/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 3, 5
Data de depósito
28/01/2016
Data de registro
11/09/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
28/03/2025
Última transação
16/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
16
Localização do titular
DE
Examinador
BLANE, SUZANNE
Unidade examinadora
M50
Localização atual
TMO LAW OFFICE 114
Titulares e representantes
Titulares
JeNaCell GmbH
JeNaCell GmbH
Representantes
Fuchs Patentanwälte Partnerschaft mbB
Classificação técnica
Classes Nice
Classe 1Classe 3Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Cellulose precursors and cellulose intermediates for cosmeticpharmaceuticalmedical and veterinary-medical end products; cellulose products for use in the manufacture of wound dressings; cellulose made by bacteria; cellulose for industrial purposes; cellulose gel for use in manufacturing; nanocellulose for use in manufacturing; unprocessed cellulose fleececellulose foilcellulose films and cellulose fibresall for use in manufacturing goods in the cosmetic and medical industries; cellulose fibres suspensions and cellulose gels of nanocellulose; cellulose fibres suspensions and cellulose gels of cellulose and water; unprocessed cellulose fleececellulose foilcellulose films and cellulose fibres for use in food and beverages; cellulose fibres suspensions and cellulose gels for use in food and beverages; Thickening agents being biochemical products for industrial use; cellulose and nanocellulose products as precursors for veterinarycosmetic productsparticularly for wound dressings; cellulose ingredients for use in manufacturing goods in the cosmetic and medical industries; cellulose and nanocellulose products as precursors for pharmaceutical products; cellulose-based ingredients for manufacturing goods in the cosmetics industry and the medical device industry; cellulose-based ingredients as support materialthickening and binding agents for the manufacture of cosmetics and medical productsparticularly wound dressings and skin care preparations; cellulose for the food industry; cellulose derivatives for use in manufacturing; diagnostic preparations and substances for scientific purposes; diagnostic testing materials for scientific use; * none of the above-mentioned goods being products to be taken orally; none of the above-mentioned goods being products containing collagen *
Classe 3
Cosmetics and cosmetic preparations; cellulose fleececellulose foilscellulose filmscellulose fibrescellulose fibre suspensions and cellulose gels impregnated with cosmetic active ingredientsparticularly skin care preparations; beauty masks; skin masks; facial masks; body masksunmedicated skin care preparations; * none of the above-mentioned goods being products containing collagen *
Classe 5
Pharmaceutical preparations for skin care; pantyliners; sanitary pads; medicated preparations for the treatment of burns with the exception of ready-to-use wound dressings; diagnostic preparations for pharmaceuticalmedical and veterinary purposes; * none of the above-mentioned goods are sticking plasters or plasters for medical use and none of the above-mentioned goods are ready-to-use surgical dressings; insofar as the above-mentioned goods relate to non-pharmaceutical productsthe latter are not provided for oral medication; insofar as the above-mentioned goods relate to pharmaceutical products to be taken orallythe latter are free from collagenchondroitin sulfate and/or hyaluronic acid; none of the above-mentioned goods are nutritional supplements containing collagenchondroitin sulfate and/or hyaluronic acid; none of the above-mentioned goods are products containing collagen *
Publicações
Histórico de despachos e eventos da marca no USPTO.
45 publicações encontradas
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
22/06/2026
INPC
INVALIDATION PROCESSED
22/06/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
28/11/2025
C71T
CANCELLED SECTION 71
28/03/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
18/02/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/08/2022
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
21/10/2019
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
04/10/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
15/02/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
24/01/2019
FIMP
FINAL DISPOSITION PROCESSED
24/01/2019
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
24/01/2019
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
23/01/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/01/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/12/2018
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
02/11/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
11/09/2018
PUBO
PUBLISHED FOR OPPOSITION
26/06/2018
GPNX
NOTIFICATION PROCESSED BY IB
23/06/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/06/2018
NPUB
NOTICE OF PUBLICATION
06/06/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/06/2018
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
10/04/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/03/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/03/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/03/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/03/2018
CNRT
NON-FINAL ACTION MAILED
21/11/2017
CNRT
NON-FINAL ACTION WRITTEN
21/11/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/10/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/10/2017
ALIE
ASSIGNED TO LIE
30/10/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/10/2017
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
18/10/2017
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
25/08/2017
RFNT
REFUSAL PROCESSED BY IB
05/05/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
19/04/2017
RFRR
REFUSAL PROCESSED BY MPU
19/04/2017
MAFR
APPLICATION FILING RECEIPT MAILED
18/04/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
16/04/2017
CNRT
NON-FINAL ACTION WRITTEN
15/04/2017
DOCK
ASSIGNED TO EXAMINER
14/04/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/04/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
13/04/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIOCELLIC+ ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.